Are the imaging endpoints right for your study?
Choose the modalities, grading methods, and endpoint definitions that best fit your indication and study objectives.
Complete retina-trial imaging support
From first scan to final endpoint.
Meet OIRRC at Booth E52 to discuss how we can help you define imaging endpoints, prepare sites, review images, and keep every decision clear and traceable.
Bring an active or upcoming retina study. We’ll focus the conversation on your specific imaging needs.
BoothE52 · Meet OIRRC in Vienna
Dates1–4 October 2026
VenueVIECON · Vienna, Austria
Meeting focusYour active or upcoming retina study
Trusted by teams advancing retinal therapies
What to discuss at Booth E52
Where can OIRRC strengthen your retina study?
Bring one challenge from an active or upcoming study. Our team can help you work through these five areas.
↗
Where is imaging slowing the trial?
Identify delays across site activation, image transfer, quality control, eligibility review, grading, and adjudication.
Can every site capture consistent data?
Standardize devices, acquisition methods, photographer training, and BCVA certification across countries and sites.
Where can AI help—and where is expert review essential?
Use automation for speed while keeping qualified readers responsible for clinically important decisions.
Is every read traceable and ready for review?
Maintain clear data lineage, audit trails, adjudication records, and sponsor-ready outputs.
Complete support across the trial lifecycle
How OIRRC supports your retina trial from start to finish.
We connect study design, site readiness, image review, and sponsor reporting in one managed workflow.
01 · PLAN
Plan the imaging strategy
Define modalities, acquisition standards, eligibility rules, grading conventions, and endpoints around the study objective.
See OIRRC technology ↗
02 · PREPARE
Prepare sites and standardize capture
Align devices, certify staff, train photographers, standardize BCVA, and set up secure image transfer.
See OIRRC technology ↗
03 · REVIEW
Review images quickly and consistently
Combine AI-assisted quality control with expert readers, structured grading, dual review, and adjudication.
See OIRRC technology ↗
04 · REPORT
Give sponsors real-time visibility
Track image status, queries, turnaround, grading decisions, and audit trails throughout the study.
See OIRRC technology ↗Retina priorities at EURETINA 2026
Three useful conversations to have at E52.
Bring a real study question. We’ll focus on the scientific and operational decisions behind it.
01
Dry AMD & GA
Choosing and standardizing FAF, OCT, atrophy boundaries, and longitudinal measures that can detect meaningful change.
Useful to bringYour proposed endpoint, modality mix, or analysis challenge.
02
AI in retina trials
Deciding where automation can speed up QC and analysis, and where expert review must remain in control.
Useful to bringA workflow you want to make faster without weakening oversight.
03
Global consistency
Reducing device, acquisition, and reader variability across multicentre international studies.
Useful to bringYour site plan, country mix, or recurring imaging deviations.
E52
26th EURETINA Congress · Vienna
Meet the OIRRC team at Booth E52.
Discuss the imaging strategy, operational challenges, and evidence requirements for your active or upcoming retina study.
Case study
See how OIRRC accelerated eligibility decisions.
This case study shows how AI-assisted image review, expert verification, and sponsor visibility worked together to support faster decisions without reducing scientific oversight.
1 hrRapid decisions
DualExpert verification
100%Traceable evidence
Get the case study.
Tell us what your retinal program needs to measure, accelerate, or de-risk. We’ll connect you with the right OIRRC expert for a focused conversation in Vienna.